Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03769376 · ClinicalTrials.gov registry record · NA
Histologic Comparison of Healing After Tooth Extraction With Ridge Preservation Using Two Different Xenografts
A NA study of Partial-edentulism, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT03769376: Completed NA study of Partial-edentulism, sponsored by University of Colorado, Denver.
NCT03769376 is a NA study of Partial-edentulism that has completed, run by University of Colorado, Denver. The registered enrollment target is 38 participants, below the 58-participant average among 3 other Partial-edentulism trials with a reported enrollment target (34% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03769376, a NA study of Partial-edentulism, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the speed of bone healing of the two most commonly used xenografts on the market, Bio-Oss® and Salvin-Oss® using a tooth extraction ridge preservation model in participants scheduled for tooth extraction and subsequent receipt of a dental implant. Researchers hypothesize that there will be additional vital bone at 16-20 weeks with Salvin-Oss®.
Primary Outcome
The amount of new bone formation at the tooth extraction/xenograft site as measured by the percent of vital bone, residual graft, and connective tissue observed in a histological sample (a bone biopsy) obtained at the time of dental implant insertion, 16-20 weeks after extraction.
Conditions Studied
Interventions
- DEVICE Bio-Oss®
- DEVICE Salvin-Oss®
Study Locations (1)
Colorado
- University of Colorado School of Dental Medicine - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2019-05-22 |
| Est. Completion | 2021-03-15 |
| Phase | NA |
What the finished NCT03769376 record still lists
NCT03769376 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 58-participant average among 3 other Partial-edentulism trials with a reported enrollment target (34% lower).
The record links to 1 condition, with Partial-edentulism appearing as the primary indexed condition, and to 2 interventions - of which Bio-Oss® is the first listed.
NCT03769376 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT03769376 about?
NCT03769376 is a clinical study titled "Histologic Comparison of Healing After Tooth Extraction With Ridge Preservation Using Two Different Xenografts". The purpose of this study is to compare the speed of bone healing of the two most commonly used xenografts on the market, Bio-Oss® and Salvin-Oss® using a tooth extraction ridge preservation model in participants scheduled for tooth extraction and subsequent receipt of a dental implant. Researchers ...
What is the current status of trial NCT03769376?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2019-05-22. Estimated completion is 2021-03-15.
What conditions does trial NCT03769376 study?
This clinical trial studies the following conditions: Partial-edentulism.
What interventions are being tested in trial NCT03769376?
The interventions under investigation include: Bio-Oss® (DEVICE), Salvin-Oss® (DEVICE).
Who is sponsoring clinical trial NCT03769376?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03769376 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Partial-edentulism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI